Bespak has developed significant core capabilities, competencies and processes.
Bespak's business model is built to support two principal goals: helping our customers succeed in commercialising their own designs of drug delivery devices; developing proprietary designs of drug delivery devices, for sale to blue chip customers in Life Sciences. To this aim, Bespak has and will continue its diversification of the drug delivery segments in which it operates as well as increasing its share of the value added content in the supply chain.
To date Bespak has evolved the range of drug delivery opportunities from its origins in the respiratory segment to that of injectables, nasal, ocular, and point-of-care diagnostics. Bespak has also further enhanced its share of the value added in the supply chain beyond that of product design, development, industrialisation and commercial manufacturing operations, and into the handling drugs for the purposes of clinical trials and final market release on behalf of our customers.
Bespak has developed significant core capabilities, competencies and processes developed through strategic investments in skills, technologies and infrastructure that provide for the best long-term growth and profitability prospects based on the value they deliver to our customers, whether based on either customer or Bespak owned intellectual property.